Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Humanin

HN, S14G-Humanin

Quick Stats
Studies 491
Trials 100
Score 3
2015 pubmed 18 citations

Humanin protects against chemotherapy-induced stage-specific male germ cell apoptosis in rats.

Surampudi. P P; Chang. I I; Lue. Y Y; Doumit. T T; Jia. Y Y; Atienza. V V; Liu. P Y PY; Swerdloff. R S RS; Wang. C C

Key Findings

  • Humanin lowered chemotherapy‑induced germ cell death at early (I‑VI) and late (IX‑XIV) stages of the seminiferous cycle but not middle (VII‑VIII) stages.
  • When Leydig cells were eliminated, humanin still reduced germ cell death at the middle stages, showing a direct protective effect on the germ cells.
  • Humanin did not prevent the drop in testosterone production caused by a direct Leydig cell inhibitor, indicating it doesn’t act by raising testosterone levels.

Practical Outcomes

  • Humanin could be investigated as a way to protect male fertility during chemotherapy, but it’s only been shown in rats and no human dosing or safety data exist yet. Biohackers should view this as early‑stage evidence, not a ready‑to‑use supplement, and await further research before trying it for fertility or anti‑aging purposes.

Summary

In rats, the tiny protein humanin helped keep sperm‑producing cells alive when they were hit by a chemo drug, especially at the start and end of the cell‑development cycle, and it still worked even when testosterone‑making Leydig cells were gone. It didn’t boost testosterone itself.

Abstract

Humanin (HN) has cytoprotective action on male germ cells after testicular stress induced by heat and hormonal deprivation. To examine whether HN has protective effects on chemotherapy-induced male germ cell apoptosis, we treated four groups of adult rats with (i) vehicle (control), (ii) HN, (iii) cyclophosphamide (CP); or (iv) HN+CP. To investigate whether the protective effects of HN on germ cells require the presence of Leydig cells, another four groups of rats were pre-treated with ethane dimethanesulfonate (EDS), a Leydig cell toxicant, to eliminate Leydig cells. After 3 days, when Leydig cells were depleted by EDS, we administered: (i) vehicle, (ii) HN, (iii) CP; or (iv) HN+CP to rats. All rats were killed 12 h after the injection of HN and/or CP. Germ cell apoptosis was detected by TUNEL assay and quantified by numerical count. Compared with control and HN (alone), CP significantly increased germ cell apoptosis; HN +CP significantly reduced CP-induced apoptosis at early (I-VI) and late stages (IX-XIV) but not at middle stages (VII-VIII) of the seminiferous epithelial cycle. Pre-treatment with EDS markedly suppressed serum and intratesticular testosterone (T) levels, and significantly increased germ cell apoptosis at the middle (VII-VIII) stages. CP did not further increase germ cell apoptosis in the EDS-pre-treated rats. HN significantly attenuated germ cell apoptosis at the middle stages in EDS pre-treated rats. To investigate whether HN has any direct effects on Leydig cell function, adult Leydig cells were isolated and treated with ketoconazole (KTZ) to block testosterone synthesis. HN was not effective in preventing the reduction of T production by KTZ in vitro. We conclude that HN decreases CP and/or EDS-induced germ cell apoptosis in a stage-specific fashion. HN acts directly on germ cells to protect against EDS-induced apoptosis in the absence of Leydig cells and intratesticular testosterone levels are very low.

Study Information

Provider

pubmed

Year

2015

Date

2015-04-16T00:00:00.000Z

DOI

10.1111/andr.12036

Citations

18

References

54